| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients
|
Maschmeyer, G.
|
|
|
20 |
9 |
p. 1560-1564
|
article
|
| 2 |
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
|
Rabaglio, M.
|
|
|
20 |
9 |
p. 1489-1498
|
article
|
| 3 |
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|
Di Lorenzo, G.
|
|
|
20 |
9 |
p. 1535-1542
|
article
|
| 4 |
Cetuximab-induced aseptic meningitis
|
Feinstein, T.M.
|
|
|
20 |
9 |
p. 1609-1610
|
article
|
| 5 |
Dietary vitamin D and cancers of the oral cavity and esophagus
|
Lipworth, L.
|
|
|
20 |
9 |
p. 1576-1581
|
article
|
| 6 |
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
|
|
|
20 |
9 |
p. 1612
|
article
|
| 7 |
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
|
Simmons, C.
|
|
|
20 |
9 |
p. 1499-1504
|
article
|
| 8 |
Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable disease
|
Jara Sánchez, C.
|
|
|
20 |
9 |
p. 1607-1608
|
article
|
| 9 |
Early detection of second breast cancers improves prognosis in breast cancer survivors
|
Houssami, N.
|
|
|
20 |
9 |
p. 1505-1510
|
article
|
| 10 |
Editorial Board
|
|
|
|
20 |
9 |
p. ii-iii
|
article
|
| 11 |
Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008
|
Cohen, J.I.
|
|
|
20 |
9 |
p. 1472-1482
|
article
|
| 12 |
Estrogen concentrations in beef and human hormone-dependent cancers
|
Handa, Y.
|
|
|
20 |
9 |
p. 1610-1611
|
article
|
| 13 |
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial
|
Schoof, N.
|
|
|
20 |
9 |
p. 1548-1554
|
article
|
| 14 |
Gefitinib for advanced non-small-cell lung cancer and quality of life: expanding and improving treatment options
|
William Jr, W.N.
|
|
|
20 |
9 |
p. 1455-1457
|
article
|
| 15 |
High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma
|
Ngeow, J.Y.Y.
|
|
|
20 |
9 |
p. 1543-1547
|
article
|
| 16 |
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour
|
Rikhof, B.
|
|
|
20 |
9 |
p. 1582-1588
|
article
|
| 17 |
in this issue
|
|
|
|
20 |
9 |
p. 1453
|
article
|
| 18 |
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
|
Okines, A.F.C.
|
|
|
20 |
9 |
p. 1529-1534
|
article
|
| 19 |
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)
|
Ruhstaller, T.
|
|
|
20 |
9 |
p. 1522-1528
|
article
|
| 20 |
Non-small-cell lung cancer: should histology guide chemotherapy treatment?
|
Bennouna, J.
|
|
|
20 |
9 |
p. 1608-1609
|
article
|
| 21 |
Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer
|
Hanauske, A.-R.
|
|
|
20 |
9 |
p. 1565-1575
|
article
|
| 22 |
Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group)
|
Witteveen, P.O.
|
|
|
20 |
9 |
p. 1511-1516
|
article
|
| 23 |
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel
|
Sekine, I.
|
|
|
20 |
9 |
p. 1483-1488
|
article
|
| 24 |
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
|
Jarnagin, W.R.
|
|
|
20 |
9 |
p. 1589-1595
|
article
|
| 25 |
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant
|
Hall, M.J.
|
|
|
20 |
9 |
p. 1517-1521
|
article
|
| 26 |
Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib
|
Cathomas, R.
|
|
|
20 |
9 |
p. 1606-1607
|
article
|
| 27 |
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group
|
Debourdeau, P.
|
|
|
20 |
9 |
p. 1459-1471
|
article
|
| 28 |
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
|
Neyns, B.
|
|
|
20 |
9 |
p. 1596-1603
|
article
|
| 29 |
Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy
|
Wong, A.L.
|
|
|
20 |
9 |
p. 1605-1606
|
article
|
| 30 |
Table of Contents
|
|
|
|
20 |
9 |
p. iv-v
|
article
|
| 31 |
Use of chemotherapy at end of life in oncology patients
|
Kao, S.
|
|
|
20 |
9 |
p. 1555-1559
|
article
|
Journal description